Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

Unsurprisingly, Akero owes this incredible one-day gain to data from a midstage clinical trial. Akero Therapeutics is ...

New research suggests that Ozempic and similar weight loss medications have the potential to be as big a game changer in ...

Research on the gut microbiome has triggered a 'revolution' in nutritional science, and in the last few years, dietary fiber ...

Drugmakers have poured small fortunes into the development of weight loss medicines in the past few years in attempts to lead ...